Quinoflox 100 mg/ml Solution for Injection for Cattle and Pigs

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Enrofloxacin

Available from:

Global Vet Health S.L.

ATC code:

QJ01MA90

INN (International Name):

Enrofloxacin

Pharmaceutical form:

Solution for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cattle, Pigs

Therapeutic area:

Antimicrobial

Authorization status:

Authorized

Authorization date:

2012-12-19

Summary of Product characteristics

Revised: March 2023
AN: 00833/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Quinoflox 100 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Enrofloxacin
100.0 mg
EXCIPIENTS:
Benzyl alcohol
0.02 ml
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATTLE
Treatment of infections of the respiratory tract caused by _
Mannheimia haemolytica, _
_Mycoplasma _spp and_ Pasteurella multocida_.
Treatment of infections of the alimentary tract caused by _Escherichia
coli_.
Treatment of septicaemia caused by _Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to _ Mycoplasma
bovis _ in
cattle less than 2 years old.
PIGS
Treatment
of
infections
of
the
respiratory
tract
caused
by
_Actinobacillus _
_pleuropneumoniae, Mycoplasma _spp. and_Pasteurella multocida . _
Treatment of infections of the urinary tract caused by _Escherichia
coli. _
Revised: March 2023
AN: 00833/2022
Page 2 of 8
Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome)
caused by
_Escherichia coli _and _Klebsiella _spp.
Treatment of infections of the alimentary tract caused by _Escherichia
coli_.
Treatment of septicaemia caused by _Escherichia coli_.
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in growing horses because of possible deleterious damage on
articular
cartilage.
Do not use in animals with central nervous system-associated seizure
disorders.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
Degenerative changes of articular cartilage were observed in calves
treated orally
with 30 mg enrofloxacin/kg bw during 14 days.
Do not use in the presence